We are live on
!
Find out more
MWNA
Marshall Wace North America Portfolio holdings
AUM
$23.5B
1-Year Est. Return
46.46%
This Fund
S&P 500
This Quarter
Est. Return
+7.23%
1 Year Est. Return
+46.46%
3 Year Est. Return
+109.4%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$17.7B
AUM Growth
-$2.27B
(-11%)
Cap. Flow
-$3.05B
Cap. Flow
% of AUM
-17.25%
Top 10 Holdings %
Top 10 Hldgs %
15.77%
Holding
1,947
New
557
Increased
335
Reduced
444
Closed
606
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vertex Pharmaceuticals
VRTX
|
+$113M |
| 2 |
BERY
Berry Global Group, Inc.
BERY
|
+$106M |
| 3 |
Merck
MRK
|
+$95.9M |
| 4 |
Baidu
BIDU
|
+$85.8M |
| 5 |
IQVIA
IQV
|
+$83.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson & Johnson
JNJ
|
+$229M |
| 2 |
Las Vegas Sands
LVS
|
+$150M |
| 3 |
Alibaba
BABA
|
+$131M |
| 4 |
Citigroup
C
|
+$130M |
| 5 |
Micron Technology
MU
|
+$105M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 24.85% |
| 2 | Technology | 15.39% |
| 3 | Consumer Discretionary | 13.45% |
| 4 | Industrials | 10.48% |
| 5 | Financials | 9.65% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1126
Clearwater Paper
CLW
$376M
| $399K | ﹤0.01% |
+17,260
| New | +$474K |
|
|
TI
1127
DELISTED
Telecom Italia
TI
| $399K | ﹤0.01% |
+54,335
| New | +$496K |
|
1128
Natera
NTRA
$46.4B
| $392K | ﹤0.01% |
+20,843
| New | +$254K |
|
1129
Fomento Económico Mexicano
FMX
$41.7B
| $388K | ﹤0.01% |
+4,415
| New | +$390K |
|
1130
J&J Snack Foods
JJSF
$1.71B
| $388K | ﹤0.01% |
+2,547
| New | +$363K |
|
|
CY
1131
DELISTED
Cypress Semiconductor
CY
| $387K | ﹤0.01% |
24,834
-657,278
| -96% | -$10.8M |
|
|
EMWP
1132
DELISTED
Eros Media World PLC
EMWP
| $382K | ﹤0.01% |
1,468
+897
| +157% | +$221K |
|
|
CRHM
1133
DELISTED
CRH Medical Corporation
CRHM
| $380K | ﹤0.01% |
+121,833
| New | +$389K |
|
|
FINV
1134
FinVolution Group
FINV
$1.15B
| $379K | ﹤0.01% |
63,585
-380,703
| -86% | -$2.6M |
|
1135
Lincoln National
LNC
$8.81B
| $374K | ﹤0.01% |
6,000
-223,207
| -97% | -$15.3M |
|
1136
Savara
SVRA
$1.19B
| $373K | ﹤0.01% |
+32,955
| New | +$331K |
|
1137
TFS Financial
TFSL
$4.93B
| $373K | ﹤0.01% |
+23,681
| New | +$366K |
|
1138
Washington Trust Bancorp
WASH
$741M
| $373K | ﹤0.01% |
+6,415
| New | +$373K |
|
|
SYRS
1139
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
| $373K | ﹤0.01% |
+3,651
| New | +$452K |
|
|
OPTU
1140
Optimum Communications Inc
OPTU
$301M
| $369K | ﹤0.01% |
+21,608
| New | +$399K |
|
1141
DXC Technology
DXC
$1.73B
| $363K | ﹤0.01% |
4,500
-65,376
| -94% | -$5.62M |
|
1142
Manulife Financial
MFC
$73.5B
| $361K | ﹤0.01% |
+20,100
| New | +$379K |
|
|
PXD
1143
DELISTED
Pioneer Natural Resource Co.
PXD
| $360K | ﹤0.01% |
+1,900
| New | +$364K |
|
1144
e.l.f. Beauty
ELF
$5.81B
| $358K | ﹤0.01% |
23,520
-52,576
| -69% | -$997K |
|
1145
The Mosaic Company
MOS
$7.33B
| $358K | ﹤0.01% |
+12,756
| New | +$346K |
|
1146
Wipro
WIT
$20B
| $358K | ﹤0.01% |
+199,179
| New | +$363K |
|
1147
United Therapeutics
UTHR
$23.1B
| $357K | ﹤0.01% |
+3,154
| New | +$347K |
|
|
VLP
1148
DELISTED
Valero Energy Partners LP
VLP
| $357K | ﹤0.01% |
+9,385
| New | +$371K |
|
1149
Ezcorp Inc
EZPW
$1.71B
| $355K | ﹤0.01% |
+29,456
| New | +$386K |
|
1150
Metropolitan Bank Holding Corp
MCB
$1.15B
| $355K | ﹤0.01% |
+6,774
| New | +$332K |
|
Similar funds
TGHSA
PAM
HB
MWA
3SCA
HFCIV
DVC
NAM
Marshall Wace North America's Q2 2018 Portfolio in Review
As of Q2 2018, Marshall Wace North America held 1,947 positions worth $17.7B, down 11% from $20B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Marshall Wace North America withdrew a net $3.05B in Q2 2018, closing 606 positions and reducing 444 holdings. Its most notable exit was Time Warner Inc, an estimated $63.3M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 25% of assets, up from 21% a quarter earlier, followed by Technology and Consumer Discretionary.
Against the trend, Marshall Wace North America opened a new position in IQVIA worth $83.1M.
- Marshall Wace North America's largest Q2 2018 buy was IQVIA: 832,159 shares worth $83.1M.
- Marshall Wace North America added most to Vertex Pharmaceuticals in Q2 2018, an estimated $113M increase.
- Marshall Wace North America's biggest Q2 2018 reduction was Johnson & Johnson, cutting an estimated $229M.
- Marshall Wace North America fully exited Time Warner Inc in Q2 2018, selling an estimated $63.3M.
- Marshall Wace North America's ten largest holdings make up 16% of its $17.7B portfolio in Q2 2018.
- Marshall Wace North America opened 557 new positions and closed 606 in Q2 2018.
- Marshall Wace North America's portfolio value fell 11% quarter-over-quarter to $17.7B.
Based on Marshall Wace North America's 13F filing for Q2 2018, filed 14 Aug 2018.